← European Medicine Shortage Tracker · all medicines
Irbesartan currently has availability issues reported in 2 European registers: Italy, Sweden.
Shortage ATC — · also listed as: IRBESARTAN · irbesartanhydrokloridseskvihydrat · data refreshed 7 August 2026
As of 7 August 2026, 2 of the 10 tracked registers list current availability issues for Irbesartan, covering 4 affected product presentations. The longest-running open report was filed in Sweden on 2024-12-17 and has now been open for about 20 months. Where agencies state a cause, unexpectedly high demand lead with 1 of the 1 stated-cause reports. The furthest expected-resolution date currently on file is 2026-12-31; the earliest is 2026-11-12. Registers in Italy, Sweden indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇮🇹 Italy | Shortage IRBESARTAN ACCORD | 2026-04-24 | — | Elevata richiesta Alternatives: AIFA: equivalents with the same active substance are available. | register ↗ |
| 🇸🇪 Sweden | Shortage Ifirmasta 75 mg Filmdragerad tablett + 2 more productsIrbesartan Accord 75 mg Filmdragerad tablett Irbesartan Actavis 300 mg Filmdragerad tablett | 2024-12-17 | 2026-12-31 | — Alternatives: Alternative(s) available — see the national register. | register ↗ |
Every individual register entry for Irbesartan in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇸🇪 SE | Irbesartan Actavis 300 mg Filmdragerad tablett | Expected shortage | 2026-09-15 | 2026-11-15 | |
| 🇮🇹 IT | IRBESARTAN ACCORD | Shortage | 2026-04-24 | — | Elevata richiesta |
| 🇸🇪 SE | Ifirmasta 75 mg Filmdragerad tablett | Shortage | 2026-04-23 | 2026-11-12 | |
| 🇸🇪 SE | Irbesartan Accord 75 mg Filmdragerad tablett | Shortage | 2024-12-17 | 2026-12-31 |
Yes. As of 7 August 2026, availability issues are reported in: Italy, Sweden. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-11-12 to 2026-12-31. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
4 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Irbesartan: AIFA (Italy), Läkemedelsverket (Sweden). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Irbesartan — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/irbesartan/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Irbesartan availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/irbesartan/">Irbesartan shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>